Cytek Biosciences, Inc. (CTKB)

USD 3.52

(-5.88%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019
Total Assets 497.66 Million 519.47 Million 463.7 Million 219.97 Million 70.36 Million
Total Current Assets 392.06 Million 454.02 Million 432.05 Million 208.62 Million 67.76 Million
Cash And Short Term Investments 262.74 Million 341.14 Million 364.61 Million 165.23 Million 30.12 Million
Cash and Cash Equivalents 167.63 Million 296.6 Million 364.61 Million 165.23 Million 30.12 Million
Short Term Investments 95.11 Million 44.54 Million - - -
Net Receivables 56.12 Million 48.86 Million 29.76 Million 18.1 Million 17.74 Million
Inventory 60.87 Million 48.15 Million 32.17 Million 23.01 Million 18.43 Million
Other Current Assets 12.32 Million 12.95 Million 5.5 Million 445 Thousand 301 Thousand
Total Non-Current Assets 105.6 Million 65.45 Million 31.64 Million 11.35 Million 2.59 Million
Net PPE 29.25 Million 27.56 Million 5.85 Million 2.14 Million 1.04 Million
Good Will And Intangible Assets 39.26 Million 14.47 Million 14.88 Million 750 Thousand 739 Thousand
Good Will 16.18 Million 10.14 Million 10.14 Million 476 Thousand 476 Thousand
Intangible Assets 23.08 Million 4.33 Million 4.73 Million 274 Thousand 263 Thousand
Long-Term Investments 1.6 Million 1.6 Million - - 250 Thousand
Tax Assets 33.69 Million 20.45 Million 9.24 Million 7.37 Million 629 Thousand
Other Non Current Assets 1.78 Million 1.35 Million 1.66 Million 1.08 Million -63 Thousand
Other Assets 1.00 - - - -
Total Liabilities 104.6 Million 93.93 Million 56.89 Million 236 Million 112.06 Million
Total Current Liabilities 56.22 Million 49.04 Million 32.16 Million 26.53 Million 21.03 Million
Account Payables 3.03 Million 4.8 Million 3.03 Million 2.94 Million 2.34 Million
Tax Payables 1.29 Million 1.66 Million 3.87 Million 1.03 Million 571 Thousand
Short Term Debt 5.57 Million 3.51 Million 15.25 Million 2.77 Million 7.21 Million
Deferred Revenue 22.69 Million 12.98 Million 7.08 Million 4.28 Million 3.47 Million
Other Current Liabilities 24.92 Million 27.73 Million 6.79 Million 16.53 Million 8.01 Million
Total Non Current Liabilities 48.37 Million 44.89 Million 24.73 Million 209.47 Million 91.02 Million
Long-Term Debt 18.12 Million 14.58 Million -777 Thousand -404 Thousand -629 Thousand
Deferred Revenue Non Current 15.13 Million 13.12 Million 9.79 Million 3.45 Million 1.78 Million
Deferred Tax Liabilities Non Current - - - - -
Other Non Current Liabilities 11.91 Million 13.13 Million 14.94 Million 206.01 Million 89.24 Million
Other Liabilities - - - - -
Total Equity 393.06 Million 425.54 Million 406.8 Million -16.02 Million -41.7 Million
Stock Holders Equity 393.06 Million 425.29 Million 406.45 Million -16.02 Million -41.7 Million
Common Stock 131 Thousand 135 Thousand 126 Thousand 23 Thousand 21 Thousand
Retained Earnings -29.17 Million -17.03 Million -18.19 Million -22.6 Million -42.01 Million
Accumulated other comprehensive income -1.27 Million -697 Thousand 897 Thousand 65 Thousand -147 Thousand
Common Stock Equity 393.06 Million 425.29 Million 406.45 Million -16.02 Million -41.7 Million
Capital Lease Obligation 9.47 Million 12.31 Million - - -
Total Investments 96.71 Million 44.54 Million - - 250 Thousand
Total Debt 33.17 Million 18.09 Million - 2.77 Million -
Net Debt -134.45 Million -278.5 Million -364.61 Million -162.45 Million -30.12 Million

Balance Sheet Charts